Skip to main content

Table 1 Correlation between SMARCC1 expression and clinicopathological characteristics in HCC patients

From: Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma

 

Variables

SMARCC1 expression

Total

χ2

P value

low

high

Age (year)

< 50

14

25

39

0.163

0.687

≥ 50

22

33

55

  

Sex

Female

3

11

14

1.981

0.159

Male

33

47

80

  

Grade

I–II

29

31

60

8.247

0.004

III

6

27

33

  

T stage

I–II

27

33

60

3.153

0.076

III–IV

9

25

34

  

TNM stage

I–II

27

33

60

3.153

0.076

III–IV

9

25

34

  

Cirrhosis

Negative

7

12

19

0.001

0.981

Positive

26

44

70

  

Hepetitis

Negative

1

4

5

0.154

0.695

Positive

35

54

89

  

AFP#

Negative

16

17

33

2.459

0.117

Positive

15

33

48

  

Cytokeratin-19 #

Negative

29

35

64

4.176

0.041

Positive

7

23

30

  
  1. #These results are based on IHC of liver specimens